The Effect of Aromatherapy for First Dental Visit Patients

September 12, 2024 updated by: He Cai, Sichuan University

The Effect of Aromatherapy on Anxiety and Pain for First Dental Visit Patients: a Randomized Controlled Clinical Trial

First dental visit experience is strongly correlated with dental anxiety, the aim of this protocol is to explore the efficacy of olfactory aromatherapy for the reduce of dental anxiety and pain in first-visit patient.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • West China Hospital of Stomatology Sichuan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients who never visited dental clinics before;
  • Patients who need dental treatment, such as resin filling, root canal treatment, periodontal initial treatment, tooth extraction, etc;
  • Patients and their guardians who are able to understand the purpose of the study and volunteer to take part in the study;
  • Patients who are intellectually sufficient to complete the anxiety scale;
  • Be able to complete all assessments and follow-up during the study.

Exclusion Criteria:

  • Patients who are allergic to the ingredients of the essential oils used in the experiment or to the materials used in the dental treatment;
  • Patients who underwent only an oral examination;
  • Patients with severe heart disease, hypertension, respiratory disease, or other systemic conditions that were not eligible for trial participation;
  • Pregnant or lactating women;
  • People with depressive symptoms, anxiety disorders or other mental illnesses that affect their mood state;
  • People who are using sedative or analgesic drugs;
  • Recent or current users of essential oils;
  • Any circumstances considered by the investigator to be inappropriate for participation in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1: single-note lavender essential oil
Aroma diffuser with single-note lavender essential oil.
In a space of 3*4*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note lavender essential oil into the aroma diffuser reservoir containing 120 ml of water.
Experimental: Group 2: single-note orange essential oil
Aroma diffuser with single-note orange essential oil
In a space of 3*4*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note orange essential oil into the aroma diffuser reservoir containing 120 ml of water.
Placebo Comparator: Group 3: deionized water
Aroma diffuser with deionized water.
In a space of 3*4*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of water into the aroma diffuser reservoir containing 120 ml of deionized water.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety scale 1 - Modified Dental Anxiety Scale (MDAS)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.
The Modified Dental Anxiety Scale (MDAS) consists of 4 questions each with a 5 category rating scale, ranging from 'not anxious' to 'extremely anxious', hence, the total score varies from 4 to 20, with higher obtained scores describing more elevated levels of dental anxiety. MDAS is recorded before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.
Pain scale - Visual Analog Scale (VAS)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." VAS is recorded before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety scale 2 - State-Trait Anxiety Inventory for State Anxiety (STAI-S)
Time Frame: 5 minutes before operation/ immediately after operation.
The STAI-S evaluates the subjective feelings of tension, worry, nervousness, apprehension, and autonomic nervous system activation. This self-completed inventory consisted of 20 items on a four-point Likert scale running from one (i.e., not at all) to four (i.e., very much). Hence, the total score varies from 20 to 80, with higher obtained scores describing more elevated levels of anxiety. STAI-S is recorded before and after operation.
5 minutes before operation/ immediately after operation.
Vital sign 1 - systolic blood pressure (SBP)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Systolic blood pressure (SBP) is measured using a manual sphygmomanometer, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Vital sign 2 - diastolic blood pressure (DBP)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Diastolic blood pressure (DBP) is measured using a manual sphygmomanometer, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Vital sign 3 - heart rate (HR)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Heart rate (HR) is measured as pulse rate using an oximeter, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Vital sign 4 - oxygen saturation (SpO2)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.
Oxygen saturation (SpO2)is measured using an oximeter, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 20, 2024

Primary Completion (Estimated)

March 31, 2025

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

September 12, 2024

First Submitted That Met QC Criteria

September 12, 2024

First Posted (Estimated)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 12, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • WCHS-CRSE-2024-128-R1-P

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Anxiety

Clinical Trials on Aroma diffuser with single-note lavender essential oil

Subscribe